Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Deferasirox (500mg) Tablet
Therapeutic Category
Nephrology
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10*10
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Deferise 500 Tablet containing Deferasirox 500 mg is a specialized iron chelation therapy designed to manage excess iron in patients with chronic transfusion requirements. It helps in reducing iron overload, preventing organ damage, and supporting overall long-term health in hematological conditions.
Deferasirox works by binding to excess iron in the body and facilitating its excretion through urine and feces, helping maintain safe iron levels and protecting vital organs such as the liver and heart from toxicity.
The formulation provides a convenient oral therapy option for iron chelation, improving patient adherence compared to more invasive methods. Its targeted mechanism ensures effective control of iron levels and reduces complications associated with chronic blood transfusions.
With increasing cases of transfusion-dependent conditions and the need for safe iron management, this tablet offers strong demand in hematology therapy segments. Its clinical reliability, consistent prescription support, and growing market acceptance make it an ideal product for expanding presence and achieving sustainable growth in the iron chelation category.
Some patients may experience nausea, vomiting, diarrhea, abdominal pain, or skin rash. Rarely, severe effects such as liver or kidney dysfunction, hearing or vision changes, or allergic reactions may occur and require immediate medical attention.
Deferise 500 Tablet is indicated for the treatment of chronic iron overload due to blood transfusions in conditions such as thalassemia, sickle cell disease, or other chronic anemias. It helps reduce excess iron levels, prevent complications associated with iron toxicity, and support overall organ health.
This medicine should be used under strict medical supervision. Patients with existing kidney or liver conditions should consult their doctor before use. Regular monitoring of iron levels, liver, and kidney function is recommended to ensure safe and effective therapy.
Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.
Composition : Atracurium (10mg) Injection
Composition : Thiocolchicoside (4mg) Capsule
Composition : Thiocolchicoside (4mg) Injection
Composition : Aceclofenac (100mg) + Paracetamol (325mg) + Chlorzoxazone (250mg) Tablet
Composition : Drotaverine (80mg) + Aceclofenac (100mg) Tablet
Composition : Aceclofenac (100mg) + Thiocolchicoside (4mg) Tablet
Composition : Aceclofenac (100mg) + Thiocolchicoside (8mg) Tablet
Composition : Baclofen (10mg) Tablet
Composition : Baclofen (20mg) Tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Deferasirox 500mg Tablet has strong demand in the hematology and chronic care segment, making it a high-value product for medical distributors, wholesalers, and pharma franchise partners looking to expand in the PCD pharma pharma franchise market.
Medical distributors and wholesalers can benefit from consistent demand in iron overload management, especially in patients requiring repeated blood transfusions such as thalassemia and chronic anemia cases. It strengthens their hematology and specialty care portfolio.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for Deferasirox 500mg Tablet with monopoly rights, quality packaging, competitive pricing, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from steady chronic therapy demand, repeat prescriptions, and strong specialty-care market opportunities when partnering with Cafoli Lifecare.
Medical distributors, stockists, wholesalers, and pharma professionals interested in this hematology formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, bulk procurement, pricing details, and distribution support services.